Cardiome Pharma Corporation Company Profile (NASDAQ:CRME)

About Cardiome Pharma Corporation

Cardiome Pharma Corporation logoCardiome Pharma Corp. (Cardiome) is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of cardiovascular therapies for heart disease. The Company's segments are Europe and Rest of World. Cardiome has two marketed, in-hospital, cardiology products, which include BRINAVESS (vernakalant IV), approved in Europe and other territories for the conversion of onset atrial fibrillation (AF) to sinus rhythm in adults, and AGGRASTAT (tirofiban hydrochloride (HCl)), indicated for use in patients with acute coronary syndrome. Cardiome also commercializes ESMOCARD and ESMOCARD LYO (esmolol hydrochloride), a short-acting beta-blocker used to control heart rate in various cardiovascular indications, in select European markets. Cardiome has also licensed TREVYENT, a development-stage drug device combination product that is under development for pulmonary arterial hypertension, in certain regions outside the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CRME
  • CUSIP:
Key Metrics:
  • Previous Close: $3.00
  • 50 Day Moving Average: $2.87
  • 200 Day Moving Average: $2.93
  • 52-Week Range: $2.35 - $6.36
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.11
  • P/E Growth: -0.15
  • Market Cap: $95.63M
  • Outstanding Shares: 31,876,000
  • Beta: 1.07
Profitability:
  • Net Margins: -93.43%
  • Return on Equity: -92.96%
  • Return on Assets: -38.52%
Debt:
  • Debt-to-Equity Ratio: 0.48%
  • Current Ratio: 4.65%
  • Quick Ratio: 4.19%
Additional Links:
Companies Related to Cardiome Pharma Corporation:

Analyst Ratings

Consensus Ratings for Cardiome Pharma Corporation (NASDAQ:CRME) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $6.95 (131.67% upside)

Analysts' Ratings History for Cardiome Pharma Corporation (NASDAQ:CRME)
Show:
DateFirmActionRatingPrice TargetDetails
12/22/2016Leerink SwannInitiated CoverageOutperform$4.75View Rating Details
11/9/2016Bloom BurtonReiterated RatingBuyView Rating Details
10/12/2016MackieReiterated RatingSpeculative Buy -> Hold$5.10 -> $3.50View Rating Details
8/15/2016Brean CapitalReiterated RatingBuy$10.00 -> $7.00View Rating Details
6/1/2016HC WainwrightInitiated CoverageBuy$9.50View Rating Details
3/13/2016Canaccord GenuityReiterated RatingBuy$10.00View Rating Details
8/14/2015LB SecuritiesReiterated RatingBuy$12.50View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Cardiome Pharma Corporation (NASDAQ:CRME)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016Q316($0.20)($0.19)$5.68 million$5.20 millionViewListenView Earnings Details
8/9/2016Q216($0.19)($0.37)$6.73 million$5.90 millionViewN/AView Earnings Details
5/13/2016Q116($0.21)($0.06)$6.34 million$7.10 millionViewListenView Earnings Details
3/10/2016Q415($0.19)($0.37)$7.74 million$4.70 millionViewListenView Earnings Details
11/13/2015Q315($0.23)($0.31)$7.08 million$5.00 millionViewListenView Earnings Details
8/5/2015Q215($0.25)($0.43)$7.67 million$5.70 millionViewN/AView Earnings Details
5/13/2015Q115($0.28)($0.23)$7.48 million$5.50 millionViewListenView Earnings Details
3/12/2015Q414($0.14)($0.39)$8.54 million$7.00 millionViewN/AView Earnings Details
11/7/2014Q314($0.13)($0.26)$6.80 millionViewN/AView Earnings Details
8/11/2014($0.16)($0.26)ViewN/AView Earnings Details
5/12/2014Q114($0.11)($0.20)$8.08 million$7.60 millionViewN/AView Earnings Details
3/27/2014($0.22)($0.53)ViewN/AView Earnings Details
11/6/2013Q3 13($0.21)($0.29)ViewN/AView Earnings Details
8/2/2013Q2 13($0.19)($0.22)ViewN/AView Earnings Details
5/13/2013Q113$1.48$1.47$1.60 millionViewN/AView Earnings Details
3/15/2013Q412($0.05)$0.13$0.84 millionViewN/AView Earnings Details
11/13/2012Q312($0.11)($0.22)ViewN/AView Earnings Details
11/4/2011($0.10)($0.12)ViewN/AView Earnings Details
5/16/2011($0.11)($0.12)ViewN/AView Earnings Details
3/10/2011($0.08)($0.12)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cardiome Pharma Corporation (NASDAQ:CRME)
Current Year EPS Consensus Estimate: $-0.73 EPS
Next Year EPS Consensus Estimate: $-0.37 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.14)($0.13)($0.14)
Q2 20161($0.24)($0.24)($0.24)
Q3 20161($0.30)($0.30)($0.30)
Q4 20162($0.18)($0.17)($0.18)
Q1 20171($0.09)($0.09)($0.09)
Q2 20171($0.11)($0.11)($0.11)
Q3 20171($0.10)($0.10)($0.10)
Q4 20171($0.07)($0.07)($0.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cardiome Pharma Corporation (NASDAQ:CRME)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cardiome Pharma Corporation (NASDAQ:CRME)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Cardiome Pharma Corporation (NASDAQ:CRME)
DateHeadline
News IconTrading Views: Watching Shares of Cardiome Pharma Corp. (CRME) - Davidson Register (NASDAQ:CRME)
davidsonregister.com - February 10 at 9:53 PM
News IconSell-side is Weighing in on Cardiome Pharma Corporation (NASDAQ:CRME) Earnings - Aiken Advocate (NASDAQ:CRME)
aikenadvocate.com - February 9 at 10:00 PM
News IconChart Level Analysis on Shares of Cardiome Pharma Corp. (CRME) - Sherwood Daily (NASDAQ:CRME)
sherwooddaily.com - February 3 at 9:48 PM
News IconTrading Insight: Taking a Look at Levels for Cardiome Pharma Corp. (CRME) - Sherwood Daily (NASDAQ:CRME)
sherwooddaily.com - February 3 at 2:57 AM
News IconTrading Scope: ADX and CCI Review for Cardiome Pharma Corp. (CRME) - Sherwood Daily (NASDAQ:CRME)
sherwooddaily.com - February 1 at 9:51 PM
News IconAre Analysts Forecasting a Near-Term Upswing For Cardiome Pharma Corporation (NASDAQ:CRME)? - Wall Street Beacon (NASDAQ:CRME)
wsbeacon.com - February 1 at 9:51 PM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Cardiome Pharma Corp. (NASDAQ:CRME) - Nelson Research (NASDAQ:CRME)
nelsonobserver.com - February 1 at 4:33 AM
News IconStock in the Limelight: Cardiome Pharma Corp. (NASDAQ:CRME) - Prospect Journal (NASDAQ:CRME)
prospectjournal.com - February 1 at 4:33 AM
News IconWhat are Brokerage Firms Saying About Cardiome Pharma Corporation (NASDAQ:CRME)? - Aiken Advocate (NASDAQ:CRME)
aikenadvocate.com - January 26 at 5:38 PM
News IconBrokers Release Average Price Target Of 9.98 On Cardiome Pharma Corporation (CRME) - UK Market News (NASDAQ:CRME)
www.ukmarketnews.co.uk - January 26 at 3:43 AM
seekingalpha.com logoRecent analyst action - Seeking Alpha (NASDAQ:CRME)
seekingalpha.com - December 23 at 4:42 PM
marketexclusive.com logoAnalyst Activity – Leerink Swann Initiates Coverage On Cardiome Pharma Corp. (NASDAQ:CRME) With a Outperform (NASDAQ:CRME)
marketexclusive.com - December 23 at 2:44 AM
streetinsider.com logoLeerink Partners Starts Cardiome Pharma (CRME) at Outperform (NASDAQ:CRME)
www.streetinsider.com - December 22 at 4:38 PM
finance.yahoo.com logoCoverage initiated on Cardiome Pharma by Leerink Partners (NASDAQ:CRME)
finance.yahoo.com - December 22 at 4:38 PM
News IconBreakout Session Alert as Shares Pop BMO: Cardiome Pharma Corp. (NASDAQ:CRME) - Prospect Journal (NASDAQ:CRME)
prospectjournal.com - December 20 at 9:29 AM
streetinsider.com logoCardiome Pharma (CRME) Initiated Commercial Launch of XYDALB in Germany - StreetInsider.com (NASDAQ:CRME)
www.streetinsider.com - December 20 at 9:29 AM
News IconStock Propelling Higher as it is Gapping up: Cardiome Pharma Corp. (NASDAQ:CRME) - Prospect Journal (NASDAQ:CRME)
prospectjournal.com - December 17 at 4:44 PM
insidermonkey.com logoIs CARDIOME PHARMA CORP (CRME) a Good Stock to Buy? (NASDAQ:CRME)
www.insidermonkey.com - December 13 at 10:09 PM
News IconTop Rated Stock With Earnings Growth & Implied Upside: Cardiome Pharma Corp. (NASDAQ:CRME) - Prospect Journal (NASDAQ:CRME)
prospectjournal.com - December 12 at 4:48 PM
us.rd.yahoo.com logo11:56 am Cardiome Pharma launches XYDALBA in the UK earlier than expected (NASDAQ:CRME)
us.rd.yahoo.com - December 8 at 9:23 PM
streetinsider.com logoCardiome Pharma (CRME) Announces Early Launch of XYDALBA in the U.K. - StreetInsider.com (NASDAQ:CRME)
www.streetinsider.com - December 8 at 4:23 PM
News IconPenny Stock Alert: Cardiome Pharma Corp (COM) Is Yet to See Trading Action on Dec 6 - Herald KS (NASDAQ:CRME)
heraldks.com - December 6 at 9:48 PM
News IconCardiome Pharma Corporation (CRME) Analyst Coverage - NewsDen (NASDAQ:CRME)
newsden.net - December 2 at 4:51 PM
News IconCardiome Pharma Corporation (CRME) Under Analyst Spotlight - UK Market News (NASDAQ:CRME)
www.ukmarketnews.co.uk - November 30 at 4:36 PM
investornewswire.com logoBuy Calls Of Cardiome Pharma Corporation (NASDAQ:CRME) At 1 - Investor Newswire (NASDAQ:CRME)
www.investornewswire.com - November 30 at 4:36 PM
streetinsider.com logoCardiome Pharma (CRME) Moves Closer to XYDALBA Launch in the UK - StreetInsider.com (NASDAQ:CRME)
www.streetinsider.com - November 30 at 9:45 AM
finance.yahoo.com logo8:01 am Cardiome Pharma moves one step closer to launching XYDALBA in the UK (NASDAQ:CRME)
finance.yahoo.com - November 30 at 9:45 AM
News IconSell-side is Weighing in on Cardiome Pharma Corporation (NASDAQ:CRME) Earnings - CSZ News (NASDAQ:CRME)
cincysportszone.com - November 25 at 9:41 AM
News IconShare Focus: Checking the Indicators on Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 25 at 9:41 AM
News IconStock Strength Review on Shares of Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 23 at 10:04 PM
News IconPenny Stock Spotlight: Focusing on Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 23 at 10:04 PM
News IconMA in Focus for Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 22 at 4:00 PM
News IconWonder Stock Alert: Investors Curious About Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 22 at 4:00 PM
News IconTechnical Watch on These Shares: Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 21 at 10:28 PM
News IconPenny Stock Making Waves: Investors Keen on Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 21 at 10:28 PM
News IconMarket Review: Indicator Watch for Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 20 at 8:31 AM
News IconTechnical Level Spotcheck on Shares of Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 18 at 8:48 PM
News IconPenny Stock Focus: Narrowing the Lens On Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 18 at 8:48 PM
News IconPenny Stock Making Waves: Taking a Second Look at Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 17 at 3:38 PM
News IconAverage Directional Index in Review for Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 16 at 4:28 PM
News IconInvestor Chatter: Tracking Technical Indicators for Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 15 at 4:45 PM
News IconPenny Stock Making News: Putting the Microscope On Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 14 at 9:56 PM
News IconPenny Stock News: Looking Closer At Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 12 at 11:42 AM
News IconIndicator Review on Shares of Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 11 at 9:06 PM
News IconTrading Radar: Checking Technicals for Cardiome Pharma Corp. (CRME) - MicroCap Wired (NASDAQ:CRME)
www.microcapwired.com - November 10 at 3:54 PM
News IconNewsworthy Penny Stock: Zeroing In On Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 10 at 3:54 PM
News IconPenny Stock Interest: Checking In On Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 10 at 3:54 PM
capitalcube.com logoCardiome Pharma Corp. :CRME-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 (NASDAQ:CRME)
www.capitalcube.com - November 9 at 1:31 PM
News IconPenny Stock Update: Traders Looking Closely at Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME)
www.duncanindependent.com - November 8 at 9:50 PM
News IconSteady as She Goes: Analysts Have High Expectations for Cardiome Pharma Corp. (NASDAQ:CRME) - CSZ News (NASDAQ:CRME)
cincysportszone.com - November 8 at 3:21 PM

Social

What is Cardiome Pharma Corporation's stock symbol?

Cardiome Pharma Corporation trades on the NASDAQ under the ticker symbol "CRME."

Where is Cardiome Pharma Corporation's stock going? Where will Cardiome Pharma Corporation's stock price be in 2017?

6 brokerages have issued 12 month price objectives for Cardiome Pharma Corporation's stock. Their forecasts range from $3.50 to $10.00. On average, they expect Cardiome Pharma Corporation's share price to reach $6.95 in the next twelve months.

Who owns Cardiome Pharma Corporation stock?

Cardiome Pharma Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Stonepine Capital Management LLC (9.91%), Clough Capital Partners L P (9.60%), AlphaOne Investment Services LLC (1.73%) and Renaissance Technologies LLC (0.67%).

Who sold Cardiome Pharma Corporation stock? Who is selling Cardiome Pharma Corporation stock?

Cardiome Pharma Corporation's stock was sold by a variety of institutional investors in the last quarter, including AlphaOne Investment Services LLC.

Who bought Cardiome Pharma Corporation stock? Who is buying Cardiome Pharma Corporation stock?

Cardiome Pharma Corporation's stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC and Renaissance Technologies LLC.

How do I buy Cardiome Pharma Corporation stock?

Shares of Cardiome Pharma Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cardiome Pharma Corporation stock cost?

One share of Cardiome Pharma Corporation stock can currently be purchased for approximately $3.00.

Cardiome Pharma Corporation (NASDAQ:CRME) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Cardiome Pharma Corporation (NASDAQ:CRME)

Earnings History Chart

Earnings by Quarter for Cardiome Pharma Corporation (NASDAQ:CRME)

Dividend History Chart

Dividend Payments by Quarter for Cardiome Pharma Corporation (NASDAQ:CRME)

Last Updated on 2/21/2017 by MarketBeat.com Staff